162 related articles for article (PubMed ID: 22921974)
1. Prevention of thromboembolic events after bioprosthetic aortic valve replacement: what is the optimal antithrombotic strategy?
Whitlock RP; Eikelboom JW
J Am Coll Cardiol; 2012 Sep; 60(11):978-80. PubMed ID: 22921974
[No Abstract] [Full Text] [Related]
2. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
[TBL] [Abstract][Full Text] [Related]
3. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulation in patients with mechanical valve prostheses: evolving protocols with new generation devices.
Cotrufo M; De Feo M; De Santo LS; Della Corte A; Scardone M; Costanza S
Ital Heart J; 2005 May; 6(5):401-4. PubMed ID: 15934413
[No Abstract] [Full Text] [Related]
5. Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement.
Christersson C; James SK; Lindhagen L; Ahlsson A; Friberg Ö; Jeppsson A; Ståhle E
Heart; 2020 Jun; 106(11):838-844. PubMed ID: 31757813
[TBL] [Abstract][Full Text] [Related]
6. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
[TBL] [Abstract][Full Text] [Related]
7. Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System.
Bravata DM; Coffing JM; Kansagara D; Myers J; Murphy L; Homoya BJ; Perkins AJ; Snow K; Quin JA; Zhang Y; Myers LJ
JAMA Surg; 2019 Feb; 154(2):e184679. PubMed ID: 30586138
[TBL] [Abstract][Full Text] [Related]
8. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
[TBL] [Abstract][Full Text] [Related]
9. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
10. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China.
Zhang H; Dong Y; Ao X; Fu B; Dong L;
Cardiovasc Drugs Ther; 2021 Feb; 35(1):1-10. PubMed ID: 32940891
[TBL] [Abstract][Full Text] [Related]
12. Incidence of anticoagulation in patients with bioprostheses.
Gherli T; Colli A; Nicolini F
J Heart Valve Dis; 2004 May; 13 Suppl 1():S88-9. PubMed ID: 15225014
[No Abstract] [Full Text] [Related]
13. Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience.
Lee SI; Lee KS; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):128-134. PubMed ID: 28367855
[TBL] [Abstract][Full Text] [Related]
14. Should we anticoagulate after bioprosthetic aortic valve replacement?
Al-Atassi T; Toeg H; Ruel M
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1649-57. PubMed ID: 24215195
[TBL] [Abstract][Full Text] [Related]
15. [The difficult choice of antithrombotic therapy after bioprosthetic aortic valve implantation: aspirin, warfarin, or both?].
Marullo AG; Iacò AL; Calafiore AM
G Ital Cardiol (Rome); 2013 Apr; 14(4):246-7. PubMed ID: 23567764
[No Abstract] [Full Text] [Related]
16. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Colli A; Verhoye JP; Leguerrier A; Gherli T
Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
van der Wall SJ; Umans VA; Schotten J; Keijzers M; Wolterbeek R; Jansen EK; Huisman MV; Vonk AB
Eur J Cardiothorac Surg; 2016 Apr; 49(4):1157-63. PubMed ID: 26233944
[TBL] [Abstract][Full Text] [Related]
18. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Goldsmith I; Lip GY; Mukundan S; Rosin MD
J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
[TBL] [Abstract][Full Text] [Related]
19. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
Colli A; Mestres CA; Castella M; Gherli T
J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
[TBL] [Abstract][Full Text] [Related]
20. [Anticoagulation after heart valve bioprosthesis].
Hamm CW
Dtsch Med Wochenschr; 1991 Mar; 116(13):514. PubMed ID: 2007385
[No Abstract] [Full Text] [Related]
[Next] [New Search]